Moore Capital Management’s PolyPid PYPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,173
Closed -$719K 832
2021
Q4
$719K Sell
4,173
-5,158
-55% -$1.09M 0.01% 472
2021
Q3
$2.18M Sell
9,331
-68
-0.7% -$16.6K 0.03% 435
2021
Q2
$2.55M Sell
9,399
-48
-0.5% -$13.3K 0.04% 406
2021
Q1
$2.6M Buy
9,447
+211
+2% +$68.7K 0.03% 393
2020
Q4
$2.76M Buy
9,236
+2,232
+32% +$711K 0.03% 315
2020
Q3
$2.31M Buy
7,004
+166
+2% +$68.8K 0.04% 253
2020
Q2
$3.7M Buy
+6,838
New +$3.83M 0.1% 164

Other funds holding PYPD

Moore Capital Management's PYPD Position: Q1 2022 in Review

Moore Capital Management sold out of PolyPid (PYPD) in Q1 2022, closing a stake of 4,173 shares — an estimated $719K sold.

Moore Capital Management first reported a position in PYPD in Q2 2020 and held it in 7 quarters. The position peaked at $3.7M in Q2 2020. 27 funds tracked by Wall St. Rank hold PYPD as of Q1 2022.

  • Moore Capital Management reported no remaining PolyPid position as of Q1 2022 after selling out during the quarter.
  • Moore Capital Management sold 4,173 PolyPid shares in Q1 2022, an estimated $719K.
  • Moore Capital Management first reported a position in PolyPid in Q2 2020 and held it in 7 quarters.
  • Moore Capital Management's PolyPid position peaked at $3.7M in Q2 2020.
  • 27 funds tracked by Wall St. Rank held PolyPid as of Q1 2022.

Based on Moore Capital Management's 13F filing for Q1 2022, filed 16 May 2022.